Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Mesalazine-Mesalamine-5-aminosalicylic acid-5-ASA

4

V.a Pleural effusion (uni- or bilateral) (can accompany DI-LDs)

1
Last update : 29/08/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Balsalazide
1

Publications

Mesalamine-associated pleural effusion with pulmonary infiltration.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1998 Nov 01;55;2304-5 1998 Nov 01
Mesalazine toxicity.
BMJ (Clinical research ed.) 1994 Feb 19;308;533-4 1994 Feb 19

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies